{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:51:56Z","timestamp":1791503516888,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.japh.2026.103520","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:22:39Z","timestamp":1788949359000},"page":"103520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular risk factor measurement patterns in patients with severe mental illness receiving comprehensive medication management pharmacist care"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2976-1993","authenticated-orcid":false,"given":"R. May","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-1862","authenticated-orcid":false,"given":"Alicia","family":"Zagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Heins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2026.103520_bib2","series-title":"Mental and substance use disorders prevalence study (MDPS): Findings report","author":"Ringeisen","year":"2023"},{"key":"10.1016\/j.japh.2026.103520_bib3","series-title":"Data from: Collaborative Psychiatric Epidemiology Surveys (CPES), 2001-2003 [United States]","author":"Alegria","year":"2024"},{"key":"10.1016\/j.japh.2026.103520_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102294","article-title":"Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis","volume":"65","author":"Chan","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.japh.2026.103520_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/acps.13715","article-title":"Cardiovascular mortality in bipolar disorder: Population-based cohort study","volume":"150","author":"Paljarvi","year":"2024","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.japh.2026.103520_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002373","article-title":"Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden","volume":"3","author":"Westman","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.japh.2026.103520_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/wps.20384","article-title":"Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas","volume":"16","author":"Liu","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.japh.2026.103520_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2020.11.002","article-title":"Premature mortality associated with severe mental illness or substance use disorder in an integrated health care system","volume":"68","author":"Iturralde","year":"2021","journal-title":"Gen Hosp Psychiatry"},{"issue":"12","key":"10.1016\/j.japh.2026.103520_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025621","article-title":"Interaction between race, ethnicity, severe mental illness, and cardiovascular disease","volume":"11","author":"O'Gallagher","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.japh.2026.103520_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021444","article-title":"Cardiovascular risk for patients with and without schizophrenia, schizoaffective disorder, or bipolar disorder","volume":"11","author":"Rossom","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.japh.2026.103520_bib11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s11096-023-01600-1","article-title":"Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines","volume":"45","author":"Carolan","year":"2023","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"10.1016\/j.japh.2026.103520_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.japh.2026.103520_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/eurheartj\/ehae054","article-title":"Severe mental illness: cardiovascular risk assessment and management","volume":"45","author":"Polcwiartek","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.japh.2026.103520_bib16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.japh.2026.103520_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1472-6963-12-166","article-title":"Factors affecting hospital stay in psychiatric patients: the role of active comorbidity","volume":"12","author":"Douzenis","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.japh.2026.103520_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/fampra\/cml054","article-title":"Physical health care of patients with schizophrenia in primary care: a comparative study","volume":"24","author":"Roberts","year":"2006","journal-title":"Fam Pract"},{"issue":"2","key":"10.1016\/j.japh.2026.103520_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.schres.2015.04.010","article-title":"Quality of medical care for persons with serious mental illness: a comprehensive review","volume":"165","author":"McGinty","year":"2015","journal-title":"Schizophrenia Res"},{"issue":"5, Supplement","key":"10.1016\/j.japh.2026.103520_bib20","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.japh.2020.04.016","article-title":"Metabolic monitoring of second-generation antipsychotics: evaluation of a pharmacist- and nurse-driven protocol","volume":"60","author":"Hibner","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"9","key":"10.1016\/j.japh.2026.103520_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.18553\/jmcp.2015.21.9.769","article-title":"Measurement of metabolic monitoring in youth and adult medicaid recipients prescribed antipsychotics","volume":"21","author":"Edelsohn","year":"2015","journal-title":"J Manag Care Specialty Pharm"},{"issue":"1","key":"10.1016\/j.japh.2026.103520_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12888-015-0416-y","article-title":"Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence","volume":"15","author":"Baller","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.japh.2026.103520_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/j.2051-5545.2011.tb00036.x","article-title":"Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.japh.2026.103520_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5334\/ijic.2605","article-title":"Integrated care to address the physical health needs of people with severe mental illness: a mapping review of the recent evidence on barriers, facilitators and evaluations","volume":"18","author":"Rodgers","year":"2018","journal-title":"Int J Integr Care"},{"issue":"4","key":"10.1016\/j.japh.2026.103520_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjmed.2020.12.008","article-title":"Assessing the impact of comprehensive medication management on achievement of the quadruple aim","volume":"134","author":"McFarland","year":"2021","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.japh.2026.103520_bib28","first-page":"111","article-title":"Medication optimization: integration of comprehensive medication management into practice","volume":"14","author":"McFarland","year":"2021","journal-title":"Am Health Drug Benefits"},{"issue":"6","key":"10.1016\/j.japh.2026.103520_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/acps.13017","article-title":"Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness","volume":"139","author":"Heiberg","year":"2019","journal-title":"Acta Psychiatrica Scand"},{"issue":"2","key":"10.1016\/j.japh.2026.103520_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.bp.110.084665","article-title":"Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation","volume":"199","author":"De Hert","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.japh.2026.103520_bib32","series-title":"PQA medication therapy problem categories framework","year":"2017"},{"issue":"4","key":"10.1016\/j.japh.2026.103520_bib36","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.amepre.2018.01.022","article-title":"Awareness of cardiovascular risk factors in U.S. young adults aged 18\u201339 years","volume":"54","author":"Bucholz","year":"2018","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.japh.2026.103520_bib37","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/inm.13034","article-title":"Diagnostic overshadowing: an evolutionary concept analysis on the misattribution of physical symptoms to pre-existing psychological illnesses","volume":"31","author":"Hallyburton","year":"2022","journal-title":"Int J Ment Health Nurs"},{"issue":"1","key":"10.1016\/j.japh.2026.103520_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/pop.2012.0023","article-title":"Optimal diabetes care outcomes following face-to-face medication therapy management services","volume":"16","author":"Brummel","year":"2013","journal-title":"Popul Health Management"},{"issue":"6","key":"10.1016\/j.japh.2026.103520_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10935-017-0490-7","article-title":"Lacking a primary care physician is associated with increased suffering in patients with severe mental illness","volume":"38","author":"Olsen","year":"2017","journal-title":"J Prim Prev"},{"key":"10.1016\/j.japh.2026.103520_bib40","author":"Trangle"},{"issue":"6","key":"10.1016\/j.japh.2026.103520_bib41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10488-011-0365-9","article-title":"Mental health provider perspectives regarding integrated medical care for patients with serious mental illness","volume":"39","author":"Kilbourne","year":"2012","journal-title":"Adm Policy Ment Health"},{"key":"10.1016\/j.japh.2026.103520_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/PPA.S124658","article-title":"Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness","volume":"11","author":"Velligan","year":"2017","journal-title":"Patient Prefer Adherence"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126005054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126005054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:21:50Z","timestamp":1791501710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319126005054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1544319126005054"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103520","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk factor measurement patterns in patients with severe mental illness receiving comprehensive medication management pharmacist care","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103520"}}